biobanking
Compound management market to almost double by 2023
September 24 by Pharmaceuticals & Biotechnology EditorThe global compound control market is projected to reach $424.5 million in 2023 from $215.3m in 2018, at CAGR of 14.5 per cent.
Conference Round-Up: The 12th Annual Global Biobanking Summit and The Compound & Sample Management Conference
May 27 by Pharma IQBack due to popular demand, the co-location of IQPC’s 12th Annual Global BiobankingSummit alongside the Compound and Sample Management Conference took place last week.The two events provided an apt ca...
Biobank Funding & Sustainability -Steps to Success 2015
March 19 by Pharmaceuticals & Biotechnology EditorBiobanks are acknowledged as a necessary and powerful resource for R&D with access to millions of samples and the associated data collected with them, but creating a sustainable framework for bi...
The 2015 Biobanking Industry Outlook
January 23 by Pharmaceuticals & Biotechnology EditorBiobanks sit in the heart of R&D, serving as a biological sample library for researchers and clinicians. Now, biobanks are progressing forward towards automated biobanking to improve sample mana...
Maintaining Public Trust in Biobanking - Time for True Transparency?
February 25 by Gerald ClarkeIn the digital environment, access and transparency are becoming increasingly common concerns. As technical industries, pharma and biotech have of course been involved in this debate. One of the rec...
Futureproof your Biobank - An Interview with Kathi Shea
February 19 by Gerald ClarkeBiobanks must face a broad range of demands during their operation and this must be taken into account in strategies and planning. Ahead of the Biobanking 2014 conference we spoke to Kathi Shea, for...
Environmental Monitoring of Biobanking Facilities
May 01 by Pharmaceuticals & Biotechnology EditorWhy do we actually need to monitor Biobanking Facilities? There are several reasons for that: You have to ensure the sample integrity and to document the storage conditions. Another point is t...
Ensuring Long Term Sample Integrity through Effective Monitoring of Storage Conditions
January 14 by Pharmaceuticals & Biotechnology EditorEnsuring Effective Data Management and Promoting Effective Sample Control In this presentation Peter Jackson, Managing Director, ELPRO UK, discusses why monitoring is required in biobanks, w...
Sample Quality and Integrity: Is Standardisation an Achievable Goal or a Dream?
December 05 by Pharmaceuticals & Biotechnology EditorIn this presentation Dr. Hagen von Briesen, Head of Department, Fraunhofer Institut fuer Biomedizinische Technik (IBMT), shares his insights on: What standards are required and can these standa...
Lesley J Stubbins, Director of Human Biological Sample Management on the Future of Biobanking
December 04 by Pharmaceuticals & Biotechnology EditorIn this interview Lesley J Stubbins, Director of Human Biological Sample Management, Secretariat to Pharmacovigilance Centre of Excellence at GSK, speaks to Andrea Charles from Pharma IQ, about sign...
Keynote Address: NHIR’s BioResource an Alternative to Biobanking
November 26 by Pharmaceuticals & Biotechnology EditorIn this presentation John Bradley, Director, NIHR Biomedical Research Centre, introduces the NIHR BioResource and identifies the initial focus for patient recruitment. Introducing the NI...